Roche Holding AG (RHHBY)
53.70
-1.49
(-2.70%)
USD |
OTCM |
Aug 31, 16:00
Roche Cash from Operations (Annual) : 21.47B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 21.47B |
| December 31, 2024 | 21.78B |
| December 31, 2023 | 17.24B |
| December 31, 2022 | 18.73B |
| December 31, 2021 | 22.50B |
| December 31, 2020 | 19.35B |
| December 31, 2019 | 21.97B |
| December 31, 2018 | 19.83B |
| December 31, 2017 | 17.68B |
| December 31, 2016 | 14.39B |
| December 31, 2015 | 14.86B |
| December 31, 2014 | 16.37B |
| December 31, 2013 | 15.67B |
| December 31, 2012 | 14.42B |
| December 31, 2011 | 12.91B |
| December 31, 2010 | 11.97B |
| December 31, 2009 | 15.14B |
| December 31, 2008 | 11.61B |
| Date | Value |
|---|---|
| December 31, 2007 | 10.43B |
| December 31, 2006 | 8.644B |
| December 31, 2005 | 8.153B |
| December 31, 2004 | 5.714B |
| December 31, 2003 | 5.239B |
| December 31, 2002 | 510.37M |
| December 31, 2001 | 2.962B |
| December 31, 2000 | 2.105B |
| December 31, 1999 | 997.33M |
| December 31, 1998 | 2.273B |
| December 31, 1997 | 2.396B |
| December 31, 1996 | 3.539B |
| December 31, 1995 | 2.868B |
| December 31, 1994 | 2.300B |
| December 31, 1993 | 2.014B |
| December 31, 1992 | 1.912B |
| December 31, 1991 | 1.380B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Novartis AG | 19.24B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |
| AstraZeneca PLC | 14.90B |
| Pfizer Inc. | 11.70B |